Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $391.7100 (-2.71%) ($391.4250 - $402.5900) on Fri. Mar. 22, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.96% (three month average) | | RSI | 28 | | Latest Price | $391.7100(-2.71%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -1.1% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.2% a week on average for past two weeks. | | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(59%) XLV(48%) IVW(40%) IWF(40%) QQQ(40%) | | Factors Impacting REGN price | REGN will decline at least -0.98% in a week (0% probabilities).
UUP(-11%) VXX(-10%) TLT(-6%) IFRA(-6%) TIP(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.98% (StdDev 1.96%) | | Hourly BBV | 0 () | | Intraday Trend | -2.4% | | | | | |
|
| Resistance Level | $415.93 | | 5 Day Moving Average | $402.86(-2.77%) | | 10 Day Moving Average | $407.15(-3.79%) | | 20 Day Moving Average | $415.93(-5.82%) | | To recent high | -10.9% | | To recent low | 15% | | Market Cap | $41.532b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |